GROUP ONE TRADING, L.P. - ALTAMIRA THERAPEUTICS LTD ownership

Back to all holdings Add to watchlist

ALTAMIRA THERAPEUTICS LTD's ticker is and the CUSIP is G0360L100. A total of 16 filers reported holding ALTAMIRA THERAPEUTICS LTD in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of ALTAMIRA THERAPEUTICS LTD
ValueSharesWeighting
Q3 2022$19,000
-51.3%
64,776
-19.6%
0.00%–
Q2 2022$39,000
-32.8%
80,605
+52.8%
0.00%–
Q1 2022$58,000
-38.3%
52,742
+2.2%
0.00%–
Q4 2021$94,000
+3033.3%
51,592
+3209.3%
0.00%–
Q3 2021$3,000–1,559–0.00%–
 Download
Other shareholders
ALTAMIRA THERAPEUTICS LTD shareholders Q3 2022
NameSharesValueWeighting ↓
Ikarian Capital, LLC 399,148$803,0000.06%
BOOTHBAY FUND MANAGEMENT, LLC 40,273$81,0000.00%
Renaissance Technologies 71,226$143,0000.00%
Stonebridge Capital Advisors LLC 100$00.00%
UBS Group AG 3,923$8,0000.00%
TWO SIGMA INVESTMENTS, LP 16,019$32,0000.00%
OSAIC HOLDINGS, INC. 1,936$4,0000.00%
BANK OF AMERICA CORP /DE/ 1$00.00%
WELLS FARGO & COMPANY/MN 8,435$17,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ALTAMIRA THERAPEUTICS LTD shareholders